company background image
VTRS

Viatris NasdaqGS:VTRS Stock Report

Last Price

US$11.14

Market Cap

US$13.5b

7D

1.3%

1Y

-12.6%

Updated

25 Nov, 2022

Data

Company Financials +

Viatris Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Viatris
Historical stock prices
Current Share PriceUS$11.14
52 Week HighUS$15.60
52 Week LowUS$8.42
Beta1.19
1 Month Change11.74%
3 Month Change12.75%
1 Year Change-12.63%
3 Year Change-40.68%
5 Year Change-70.78%
Change since IPO216.61%

Recent News & Updates

Recent updates

Earnings Update: Viatris Inc. (NASDAQ:VTRS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

May 13
Earnings Update: Viatris Inc. (NASDAQ:VTRS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Do Institutions Own Viatris Inc. (NASDAQ:VTRS) Shares?

Mar 12
Do Institutions Own Viatris Inc. (NASDAQ:VTRS) Shares?

Does Viatris's (NASDAQ:VTRS) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 10
Does Viatris's (NASDAQ:VTRS) Statutory Profit Adequately Reflect Its Underlying Profit?

Shareholder Returns

VTRSUS PharmaceuticalsUS Market
7D1.3%1.6%1.3%
1Y-12.6%9.9%-18.5%

Return vs Industry: VTRS underperformed the US Pharmaceuticals industry which returned 9.9% over the past year.

Return vs Market: VTRS exceeded the US Market which returned -18.5% over the past year.

Price Volatility

Is VTRS's price volatile compared to industry and market?
VTRS volatility
VTRS Average Weekly Movement6.2%
Pharmaceuticals Industry Average Movement11.0%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: VTRS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: VTRS's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
196137,000Michael Goettlerhttps://www.viatris.com

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).

Viatris Inc. Fundamentals Summary

How do Viatris's earnings and revenue compare to its market cap?
VTRS fundamental statistics
Market CapUS$13.51b
Earnings (TTM)US$803.60m
Revenue (TTM)US$16.73b

16.8x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
VTRS income statement (TTM)
RevenueUS$16.73b
Cost of RevenueUS$9.42b
Gross ProfitUS$7.31b
Other ExpensesUS$6.51b
EarningsUS$803.60m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.66
Gross Margin43.69%
Net Profit Margin4.80%
Debt/Equity Ratio104.2%

How did VTRS perform over the long term?

See historical performance and comparison

Dividends

4.3%

Current Dividend Yield

72%

Payout Ratio